Read more about Jubilant Pharmova subsidiary to invest $92 mln for expansion on Business Standard. Jubilant Pharma, a wholly-owned subsidiary of Jubilant Pharmova, announced $92 million investment plans to expand sterile injectable manufacturing capacity at its Spokane site in Washington, US.